Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer

Breast Cancer Research and Treatment

Volumn 132, Issue 1, 2012, Pages 307-315

  Blanco, Ana ^a   De La Hoya, Miguel ^b   Balmaña, Judith ^c   Ramón Y Cajal, Teresa ^d   Teulé, Alex ^e   Miramar, María Dolores ^f   Esteban, Eva ^g   Infante, Mar ^h   Benítez, Javier ⁱ   Torres, Asunción ^j   Tejada, María Isabel ^k   Brunet, Joan ^l   Graña, Begoña ^m   Balbín, Milagros ⁿ   Pérez Segura, Pedro ^b   Osorio, Ana ⁱ   Velasco, Eladio A ^h   Chirivella, Isabel ^o   Calvo, María Teresa ^f   Feliubadaló, Lidia ^e   Lasa, Adriana ^d   Díez, Orland ^p   Carracedo, Angel ^a   Caldés, Trinidad ^b   Vega, Ana ^a,q   more..

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^f HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^g HOSPITAL UNIVERSITARIO LA FE   (Spain)

^h Universidad de Valladolid y Consejo Superior de Investigaciones Científicas   (Spain)

ⁱ Centro Nacional de Investigaciones Oncológicas   (Spain)

^j HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^k HOSPITAL DE CRUCES   (Spain)

^l GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

^m Universidad de La Coruña   (Spain)

ⁿ DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^o HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^p VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^q Instituto de Salud Carlos III   (Spain)

more..

Author keywords

BRCA1 BRCA2 negative families; Familial breast cancer; Genomic rearrangement; In silico analysis; Male breast cancer; PALB2

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA;

ADULT; AGED; ARTICLE; BIOINFORMATICS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER FAMILY; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE DELETION; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC VARIABILITY; GERM LINE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MALE BREAST CANCER; MISSENSE MUTATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; OVARY CANCER; PARTNER AND LOCALIZER OF BRCA2 GENE; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

AGED; BREAST NEOPLASMS, MALE; EXONS; FEMALE; GENETIC ASSOCIATION STUDIES; GERM-LINE MUTATION; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PEDIGREE; SEQUENCE ANALYSIS, DNA; SEQUENCE DELETION; SPAIN; TUMOR SUPPRESSOR PROTEINS;

EID: 84857918420     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1842-2     Document Type: Article

References (31)

1. Venkitaraman AR (2004) Tracing the network connecting BRCA and Fanconi anemia proteins. Nat Rev Cancer 4:266-276
2. Walsh T, King MC (2007) Ten genes for inherited breast cancer. Cancer Cell 11:103-105 (Pubitemid 46209856)
3. Xia B, Sheng Q, Nakanishi K, Ohashi A, Wu J, Christ N, Liu X, Jasin M, Couch FJ, Livingston DM (2006) Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Molecular Cell 22:719-729
4. Zhang F, Ma J, Wu J, Ye L, Cai H, Xia B, Yu X (2009) PALB2 links BRCA1 and BRCA2 in the DNA-damage response. Curr Biol 19:524-529
5. Dray E, Etchin J, Wiese C, Saro D, Williams GJ, Hammel M, Yu X, Galkin VE, Liu D, Tsai MS, Sy SM, Schild D, Egelman E, Chen J, Sung P (2010) Enhancement of RAD51recombinase activity by the tumor suppressor PALB2. Nat Struct Mol Biol 17:1255-1259
6. Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T, Jayatilake H, McGuffog L, Hanks S, Evans DG, Eccles D; Breast Cancer Susceptibility Collaboration (UK), Easton DF, Stratton MR (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39:165-167 (Pubitemid 46184346)
7. Garcia MJ, Fernandez V, Osorio A, Barroso A, Llort G, Lázaro C, Blanco I, Caldés T, de la Hoya M, Ramón Y, Cajal T, Alonso C, Tejada MI, San Romaaposn C, Robles-Díaz L, Urioste M, Benítez J (2009) Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families. Breast Cancer Res Treat 113:545-551
8. Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM, Ashworth A, Tonin PN, Narod SA, Livingston DM, Foulkes WD (2007) Analysis of PALB2/FANCN-associated breast cancer families. PNAS 104: 6788-6793 (Pubitemid 47175579)
9. Foulkes WD, Ghadirian P, Akbari MR, Hamel N, Giroux S, Sabbaghian N, Darnel A, Royer R, Poll A, Fafard E, Robidoux A, Martin G, Bismar TA, Tischkowitz M, Rousseau F, Narod SA (2007) Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women. Breast Cancer Res 9:R83
10. Cao AY, Huang J, Hu Z, Li WF, Ma ZL, Tang LL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM (2009) The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with earlyonset breast cancer or affected relatives. Breast Cancer Res Treat 114:457-462
11. Sluiter M, Mew S, van Rensburg EJ (2009) PALB2 sequence variants in young South African breast cancer patients. Fam Cancer 8:347-353
12. Erkko H, Xia B, Nikkila J, Schleutker J, Syrjäkoski K, Mannermaa A, Kallioniemi A, Pylkas K, Karppinen SM, Rapakko K, Miron A, Sheng Q, Li G, Mattila H, Bell DW, Haber DA, Grip M, Reiman M, Jukkola-Vuorinen A, Mustonen A, Kere J, Aaltonen LA, Kosma VM, Kataja V, Soini Y, Drapkin RI, Livingston DM, Winqvist R (2007) A recurrent mutation in PALB2 in Finnish cancer families. Nature 446:316-319 (Pubitemid 46426155)
13. Zhang MQ (1998) Statistical features of human exons and their flanking regions. Hum Mol Genet 7:919-932
14. Yeo G, Burge CB (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 11:377-394 (Pubitemid 38901668)
15. Reese MG, Eeckman FH, Kulp D, Haussler D (1997) Improved splice site detection in Genie. J Comput Biol 4:311-323 (Pubitemid 27355870)
16. Pertea M, Lin X, Salzberg SL (2001) GeneSplicer: a new computational method for splice site prediction. Nucleic Acids Res 29:1185-1190 (Pubitemid 32186204)
17. Hellen B (November 2009) Splice site tools. A comparative analysis report
18. den Dunnen JT, Antonarakis SE (2000) Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat 15:7-12
19. Rahman N, Scott RH (2007) Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players. Hum Mol Genet 16:R60-R66 (Pubitemid 47241843)
20. Papi L, Putignano AL, Congregati C, Piaceri I, Zanna I, Sera F, Morrone D, Genuardi M, Palli D (2010) A PALB2 germline mutation associated with hereditary breast cancer in Italy. Familial Cancer 9:181-185
21. Tischkowitz M, Sabbaghian N, Hamel N, Borgida A, Rosner C, Taherian N, Srivastava A, Holter S, Rothenmund H, Ghadirian P, Foulkes WD, Gallinger S (2009) Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer. Gastroenterology 137:1183-1186
22. Dansonka-Mieszkowska A, Kluska A, Moes J, Dabrowska M, Nowakowska D, Niwinska A, Derlatka P, Cendrowski K, Kupryjanczyk J (2010) A novel germline PALB2 deletion in Polish breast and ovarian cancer patients. BMC Med Genet 11:20
23. Silvestri V, Rizzolo P, Zanna I, Falchetti M, Masala G, Bianchi S, Papi L, Giannini G, Palli D, Ottini L (2010) PALB2 mutations in male breast cancer: a population-based study in Central Italy. Breast Cancer Res Treat 122:299-301
24. Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, Parsons DW, Lin JC, Palmisano E, Brune K, Jaffee EM, Iacobuzio- Donahue CA, Maitra A, Parmigiani G, Kern SE, Velculescu VE, Kinzler KW, Vogelstein B, Eshleman JR, Goggins M, Klein AP (2009) Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324:217
25. Balia C, Sensi E, Lombardi G, Roncella M, Bevilacqua G, Caligo MA (2010) PALB2: a novel inactivating mutation in a Italian breast cancer family. Familial Cancer 9:531-536
26. Hellebrand H, Sutter C, Honisch E, Gross E, Wappenschmidt B, Schem C, Deissler H, Ditsch N, Gress V, Kiechle M, Bartram CR, Schmutzler RK, Niederacher D, Arnold N, Meindl A (2011) Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer. Hum Mutat 32:E2176-E2188
27. Pylkas K, Erkko H, Nikkila J, Soaposlyom S, Winqvist R (2008) Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families. BMC Cancer 8:146
28. Ameziane N, van den Ouweland AMW, Adank MA, Vijzelaar RN, Errami A, Dorsman JC, Joenje H, Meijers-Heijboer H, Waisfisz Q (2009) Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer. Breast Cancer Res Treat 118:651-653
29. Xia B, Dorsman JC, Ameziane N, de Vries Y, Rooimans MA, Sheng Q, Pals G, Errami A, Gluckman E, Llera J, Wang W, Livingston DM, Joenje H, de Winter JP (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet 39:159-161 (Pubitemid 46184344)
30. Sy SM, Huen MS, Chen J (2009) PALB2 is an integral component of the BRCA complex required for homologous recombination repair. PNAS 106:7155-7160
31. Sy SM, Huen MS, Zhu Y, Chen J (2009) PALB2 regulates recombinational repair through chromatin association and oligomerization. J Biol Chem 284:18302-18310